Delivery Order SPE2DB22D3016-SPE2DB25FAJV1

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,904.92, is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order that runs through January 13, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,394.05, is for the delivery of Imitrex 6 mg/0.5 ml cartridges, a specialty medication used for the treatment of migraines. The contract is a firm fixed-price delivery order with a completion date of May 29, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This federal contract award, valued at $1,917.51, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a prescription medication. The contract has a completion date of September 19, 2024 and is structured as a firm-fixed-price delivery order. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds several Indefinite...
This federal contract award, valued at $60,618.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty medication, and has an ultimate completion date of August 26, 2024. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The delivery order contract is valued at $2,944.73 and has a completion date of August 7, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, for providing a wide range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Imitrex 6 mg/0.5 ml cartridges (0.5 ml) to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $2,811.21, has a completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $39,006.43, is a delivery order for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 13, 2025 and is a firm fixed-price contract type. This award is part of a larger Indefinite Delivery Contract...
The U.S. government's Defense Logistics Agency (DLA) awarded a $3,356.36 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. This contract is for the supply of 4564677375 ! IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a prescription medication, with a completion date of May 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This is a Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 mL Injection Pens. The contract has a ceiling value of $3,681.36 and a completion date of May 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $1,681.02, is for the supply of IMITREX 6 MG/0.5 ML CARTRIDGES 0.5ML, a specialty migraine medication. The contract is a firm fixed-price delivery order with a completion date of September 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAJV1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml cartridges. The contract has a ceiling value of $1,516.35 and a completion date of January 13, 2025. It is a firm-fixed-price contract and was not set aside for any specific business type.

The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 4/11/25, 11:30 AM